We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.
- Authors
Sahni, D; Robson, A; Orchard, G; Szydlo, R; Evans, A V; Russell-Jones, R
- Abstract
Sentinel node (SN) status is the most important prognostic indicator in patients with cutaneous melanoma without clinically evident metastatic spread, but the procedure is associated with considerable morbidity. The LYVE-1 lymphatic marker offers the possibility of studying lymphangiogenesis and tumour metastasis within the primary excision.
- Publication
Journal of clinical pathology, 2005, Vol 58, Issue 7, p715
- ISSN
0021-9746
- Publication type
Journal Article
- DOI
10.1136/jcp.2004.020123